Sale!

MYOT Gene Limb-girdle muscular dystrophy autosomal dominant type 1A Genetic Test

4,400 د.إ

-21%

The MYOT gene, associated with Limb-girdle muscular dystrophy autosomal dominant type 1A (LGMD1A), plays a crucial role in the health and function of muscles, particularly those in the shoulders and hips. This condition is characterized by progressive muscle weakness and atrophy, typically manifesting in adulthood. DNA Labs UAE offers a genetic test specifically designed to detect mutations in the MYOT gene that are responsible for LGMD1A. The test is a critical tool for diagnosing individuals suspected of having this condition, enabling them to make informed decisions about their health management. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic variations associated with this form of muscular dystrophy. By opting for this test, patients and their families can gain valuable insights into their genetic makeup, potentially leading to early intervention and tailored treatment strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MYOT Gene Limb-girdle muscular dystrophy autosomal dominant type 1A Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for MYOT Gene Limb-girdle muscular dystrophy, autosomal dominant type 1A NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with MYOT Gene Limb-girdle muscular dystrophy, autosomal dominant type 1A

Test Details

The MYOT gene is associated with Limb-girdle muscular dystrophy, autosomal dominant type 1A (LGMD1A). This is a genetic disorder characterized by progressive muscle weakness and wasting primarily affecting the muscles of the hips and shoulders (limb-girdle muscles).

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. It allows for a comprehensive analysis of the genetic code, enabling the identification of mutations or variations in specific genes, such as the MYOT gene in this case.

The MYOT gene NGS genetic test involves sequencing the entire coding region of the MYOT gene to identify any pathogenic mutations or variations. This test can provide a definitive diagnosis of LGMD1A and help determine the inheritance pattern and risk of passing on the condition to offspring.

If you suspect you or someone you know may have LGMD1A, it is recommended to consult with a healthcare professional or a genetic counselor who can guide you through the testing process and provide appropriate genetic counseling.

Test Name MYOT Gene Limb-girdle muscular dystrophy autosomal dominant type 1A Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MYOT Gene Limb-girdle muscular dystrophy, autosomal dominant type 1A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MYOT Gene Limb-girdle muscular dystrophy, autosomal dominant type 1A
Test Details

The MYOT gene is associated with Limb-girdle muscular dystrophy, autosomal dominant type 1A (LGMD1A). This is a genetic disorder characterized by progressive muscle weakness and wasting primarily affecting the muscles of the hips and shoulders (limb-girdle muscles).

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. It allows for a comprehensive analysis of the genetic code, enabling the identification of mutations or variations in specific genes, such as the MYOT gene in this case.

The MYOT gene NGS genetic test involves sequencing the entire coding region of the MYOT gene to identify any pathogenic mutations or variations. This test can provide a definitive diagnosis of LGMD1A and help determine the inheritance pattern and risk of passing on the condition to offspring.

If you suspect you or someone you know may have LGMD1A, it is recommended to consult with a healthcare professional or a genetic counselor who can guide you through the testing process and provide appropriate genetic counseling.